ILMN logo

Illumina, Inc. (ILMN)

Profile

Full Name

Illumina, Inc.

Ticker

NASDAQ: ILMN

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

July 28, 2000

Indexes

Not included

Website

http://www.illumina.com

Employees

8970

Key Details

Price

$109.30(+1.54%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$4.37B(-2.93% YoY)

Annual EPS

-$7.69(-4.77% YoY)

PE ratio

-

Next earnings date

Jul 31, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $109.30
    ILMN price is $109.30

    30-Day Relative Volume

    0.82
    ILMN 30-day relative volume is 0.82

    Price Performance

    Price Most recent change

    +1.54%
    ILMN price was up +1.54% on Jul 25, 2025

    Price YTD change

    -18.21%
    ILMN price is down -18.21% since January 1st

    Price 1-year change

    -6.82%
    ILMN price is down -6.82% year-on-year

    Price 3-year change

    -43.68%
    ILMN price is down -43.68% over the past 3 years

    Price Range

    Price All-time high

    $555.77
    ILMN price is currently -80.33% below its historical high of $555.77

    Price 3-year low

    $68.70
    ILMN price is currently +59.10% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $17.30B
    ILMN market capitalization is $17.30 billion

    Market cap 3-year change

    -43.22%
    ILMN market capitalization is down -43.22% over the past 3 years

    Market cap All-time high

    $77.73B
    ILMN market capitalization is currently -77.74% below its historical high of $77.73 billion

    Market cap sector rank

    94.89%
    ILMN market capitalization is higher than 94.89% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -0.63%
    ILMN shares outstanding is down -0.63% year-on-year

    Shares Outstanding 3-Year Change

    +0.83%
    ILMN shares outstanding is up +0.83% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.03
    ILMN beta is 1.03

    200-day SMA

    $109.46
    ILMN price is currently -0.15% below its 200-day simple moving average

    50-day SMA

    $90.96
    ILMN price is currently +20.17% above its 50-day simple moving average

    RSI

    73.80
    ILMN 14-day relative strength index is 73.80

    Volume

    0.82
    ILMN 30-day relative volume is 0.82

    ATR

    $3.65
    ILMN average true range is $3.65

    10-day Historical Volatility

    45.55%
    ILMN 10-day historical volatility is 45.55%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $4.37B
    ILMN annual revenue is $4.37 billion

    Revenue Analysts estimate

    $4.24B
    ILMN annual revenue is currently +3.16% higher than the consensus analysts' forecast

    Revenue 1-year change

    -2.93%
    ILMN annual revenue is down -2.93% year-on-year

    Revenue Sector rank

    91.2%
    ILMN annual revenue is higher than 91.2% of companies in Healthcare sector

    EPS

    EPS

    -$7.69
    ILMN annual earnings per share is -$7.69

    EPS Analysts estimate

    $4.24
    ILMN annual earnings per share is currently -281.47% lower than the consensus analysts' forecast

    EPS 1-year change

    -4.77%
    ILMN annual earnings per share is down -4.77% year-on-year

    EPS Sector rank

    15.6%
    ILMN annual earnings per share is higher than 15.6% of companies in Healthcare sector

    Profit

    Gross profit

    $2.86B
    ILMN annual gross profit is $2.86 billion

    Gross margin

    65.44%
    ILMN annual gross profit margin is 65.44%

    Operating profit

    $600.00M
    ILMN annual operating income is $600.00 million

    Operating margin

    13.72%
    ILMN annual operating profit margin is 13.72%

    Net income

    -$1.22B
    ILMN annual net profit is -$1.22 billion

    Net margin

    -27.97%
    ILMN annual net profit margin is -27.97%

    Expenses

    Total expenses

    $3.77B
    ILMN annual total expenses is $3.77 billion

    Operating expenses

    $2.26B
    ILMN annual total operating expenses is $2.26 billion

    Cost of goods sold

    $1.51B
    ILMN annual cost of goods sold is $1.51 billion

    Selling, general & administrative expenses

    $1.09B
    ILMN annual SGA is $1.09 billion

    Depreciation and amortization

    $354.00M
    ILMN annual depreciation & amortization is $354.00 million

    Interest expense

    $100.00M
    ILMN annual interest expense is $100.00 million

    Income tax

    $44.00M
    ILMN annual income tax is $44.00 million

    EBIT & EBITDA

    EBIT

    $600.00M
    ILMN annual earnings before interest & taxes is $600.00 million

    EBITDA

    $600.00M
    ILMN annual EBITDA is $600.00 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $6.30B
    ILMN annual total assets is $6.30 billion

    Non current assets

    $3.56B
    ILMN annual long term assets is $3.56 billion

    Current assets

    $2.75B
    ILMN annual total current assets is $2.75 billion

    Cash and cash equivalents

    $1.13B
    ILMN annual cash & cash equivalents is $1.13 billion

    Accounts receivable

    $735.00M
    ILMN annual accounts receivable is $735.00 million

    Inventory

    $547.00M
    ILMN annual inventory is $547.00 million

    Liabilities

    Total liabilities

    $3.93B
    ILMN annual total liabilities is $3.93 billion

    Long term liabilities

    $2.38B
    ILMN annual total long term liabilities is $2.38 billion

    Current liabilities

    $1.55B
    ILMN annual total current liabilities is $1.55 billion

    Accounts payable

    $221.00M
    ILMN annual accounts payable is $221.00 million

    Debt

    Total debt

    $2.62B
    ILMN annual total debt is $2.62 billion

    Total debt 1-year change

    +15.92%
    ILMN annual total debt is up +15.92% year-on-year

    Long term debt

    $2.04B
    ILMN annual long term debt is $2.04 billion

    Short term debt

    $578.00M
    ILMN annual short term debt is $578.00 million

    Equity & Capital

    Shareholders equity

    $2.37B
    ILMN annual stockholders equity is $2.37 billion

    Book value

    $2.37B
    ILMN annual book value is $2.37 billion

    Retained earnings

    -$1.24B
    ILMN annual retained earnings is -$1.24 billion

    Working capital

    $1.20B
    ILMN annual working capital is $1.20 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $837.00M
    ILMN annual cash flow from operations is $837.00 million

    Cash from operations 1-year change

    +75.1%
    ILMN annual cash flow from operations is up +75.1% year-on-year

    Cash from investing

    -$178.00M
    ILMN annual cash flow from investing activities is -$178.00 million

    Cash from investing 1-year change

    +22.94%
    ILMN annual cash flow from investing activities is up +22.94% year-on-year

    Cash from financing

    -$570.00M
    ILMN annual cash flow from financing activities is -$570.00 million

    Cash from financing 1-year change

    +52.89%
    ILMN annual cash flow from financing activities is up +52.89% year-on-year

    CAPEX

    CAPEX

    $128.00M
    ILMN annual capital expenditures is $128.00 million

    CAPEX 1-year change

    -34.36%
    ILMN annual capital expenditures is down -34.36% year-on-year

    Free Cash Flow

    Free cash flow

    $837.00M
    ILMN annual free cash flow is $837.00 million

    Free cash flow 1-year change

    +196.81%
    ILMN annual free cash flow is up +196.81% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    65.44%
    ILMN annual gross profit margin is 65.44%

    Operating margin

    13.72%
    ILMN annual operating profit margin is 13.72%

    Net margin

    -27.97%
    ILMN annual net profit margin is -27.97%

    ROA & ROE

    ROA

    -14.90%
    ILMN annual return on assets is -14.90%

    ROE

    -30.13%
    ILMN annual return on equity is -30.13%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ILMN price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ILMN price to earnings ratio is unknown

    PB Ratio

    PB ratio

    7.31
    ILMN price to book ratio is 7.31

    PB ratio Sector rank

    84.37%
    ILMN price to book ratio is higher than 84.37% of companies in Healthcare sector

    PS Ratio

    PS ratio

    3.99
    ILMN price to sales ratio is 3.99

    PS ratio Sector rank

    56%
    ILMN price to sales ratio is higher than 56% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $18.80B
    ILMN enterprise value is $18.80 billion

    Enterprise value Sector rank

    94.66%
    ILMN enterprise value is higher than 94.66% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -40.34
    ILMN EV/EBITDA is -40.34

    EV/EBITDA Sector rank

    4.49%
    ILMN EV/EBITDA is higher than 4.49% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.78
    ILMN annual current ratio is 1.78

    Quick ratio

    1.42
    ILMN annual quick ratio is 1.42

    Leverage

    Debt to equity

    0.84
    ILMN annual debt to equity ratio is 0.84

    Interest coverage ratio

    6.00
    ILMN annual interest coverage ratio is 6.00

    Risk & Stability

    Piotroski F-Score

    7
    ILMN piotroski f-score is 7

    Altman Z-Score

    3.60
    ILMN altman z-score is 3.60

    Analyst ratings

    Recent major analysts updates

    Jul 11, 25 Scotiabank
    Sector Perform
    Jul 9, 25 Citigroup
    Sell
    Jul 8, 25 Evercore ISI Group
    Outperform
    Jun 24, 25 Barclays
    Underweight
    Jun 11, 25 Canaccord Genuity
    Hold
    May 20, 25 Stephens & Co.
    Overweight
    May 15, 25 Piper Sandler
    Overweight
    May 12, 25 Morgan Stanley
    Equal-Weight
    May 12, 25 Canaccord Genuity
    Hold
    May 9, 25 JP Morgan
    Neutral

    Institutional Ownership

    Screeners with ILMN included

    US stocks
    High Piotroski score stocks
    Stocks with high beta
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    • What is the ticker symbol for Illumina, Inc.?
    • Does Illumina, Inc. pay dividends?
    • What sector is Illumina, Inc. in?
    • What industry is Illumina, Inc. in?
    • What country is Illumina, Inc. based in?
    • When did Illumina, Inc. go public?
    • Is Illumina, Inc. in the S&P 500?
    • Is Illumina, Inc. in the NASDAQ 100?
    • Is Illumina, Inc. in the Dow Jones?
    • When was Illumina, Inc.'s last earnings report?
    • When does Illumina, Inc. report earnings?

    What is the ticker symbol for Illumina, Inc.?

    The ticker symbol for Illumina, Inc. is NASDAQ:ILMN

    Does Illumina, Inc. pay dividends?

    No, Illumina, Inc. does not pay dividends

    What sector is Illumina, Inc. in?

    Illumina, Inc. is in the Healthcare sector

    What industry is Illumina, Inc. in?

    Illumina, Inc. is in the Diagnostics & Research industry

    What country is Illumina, Inc. based in?

    Illumina, Inc. is headquartered in United States

    When did Illumina, Inc. go public?

    Illumina, Inc.'s initial public offering (IPO) was on July 28, 2000

    Is Illumina, Inc. in the S&P 500?

    No, Illumina, Inc. is not included in the S&P 500 index

    Is Illumina, Inc. in the NASDAQ 100?

    No, Illumina, Inc. is not included in the NASDAQ 100 index

    Is Illumina, Inc. in the Dow Jones?

    No, Illumina, Inc. is not included in the Dow Jones index

    When was Illumina, Inc.'s last earnings report?

    Illumina, Inc.'s most recent earnings report was on May 8, 2025

    When does Illumina, Inc. report earnings?

    The next expected earnings date for Illumina, Inc. is July 31, 2025
    On this page